OREANDA-NEWS. Olympus Medical Systems Corp. will launch the EU-ME2 endoscopic ultrasound center for endoscopic ultrasonography in the digestive and respiratory fields worldwide from November 2013.

Endoscopic ultrasonography combines endoscopy and ultrasound in order to obtain images and information about the digestive tract and surrounding tissue and organs. It uses high-frequency ultrasound waves from the tip of an ultrasound endoscope and produces images. It thus helps observe deeper organs such as the pancreas and visualize the layers of the walls of the digestive tract such as the stomach, which are difficult with extracorporeal ultrasound (from the surface of the body). Endoscopic ultrasonography is now conducted for examining cancers of the pancreas, lung, stomach and esophagus as well as diagnosing and assessing benign disease associated with these organs.

The new endoscopic ultrasound center EU-ME2 PREMIER PLUS (hereafter "EU-ME2") will be launched in this November. Like the previous model, the EU-ME2 connects to an endoscope, sends and receives ultrasound waves. The EU-ME2 realizes higher resolution images while maintaining the same compact size of the previous model.

It also features a variety of new functions, for example, for reducing artifacts and measuring the relative stiffness of tissue. In addition, it also supports clear visualization of tumors and blood flow information. Last but not least, thanks to its compact size it fits on Olympus' endoscopy system trolley, and ensures the compatibility with Olympus' endoscopy systems for efficient examinations.